Organogenesis Holdings Inc. (ORGO) stock
ORGONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$0.81+0.01 (+1.06%)
Close on Nov 17, 2026Market cap $104.43MP/E –Yield –
Organogenesis EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Organogenesis's EV/EBITDA was 11.5× on Jul 31, 2026, against 276.5× a year earlier. Over the last 5 years it ranged from 3.4× to 327.8×, with a median of 14.9×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jul 31, 2026 | 11.5× | −80.5 |
| 2025 | Dec 31, 2025 | 92.0× | −184.5 |
| 2024 | Oct 31, 2024 | 276.5× | +257.0 |
| 2023 | Dec 29, 2023 | 19.5× | +12.1 |
| 2022 | Dec 30, 2022 | 7.3× | −7.3 |
| 2021 | Dec 31, 2021 | 14.7× | −218.2 |
| 2020 | Dec 31, 2020 | 232.9× | – |
See a number that looks wrong?